Dems Seek Repeal Of Orphan-Only Drugs Exemption From Price Negotiation

Inclusion of the Orphan Cures Act in the One Big Beautiful Bill legislation implies that certain high-cost drugs with orphan indications will either no longer be eligible for Medicare price negotiation or will have their eligibility deferred.